Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats

The effect of exercise training (9 weeks of running) on norepinephrine-induced inhibition of insulin secretion was examined in rat islets. Insulin secretions from islets in the presence of glucose (> or =5.5 mmol/L) were significantly lower in trained (TR) than in control rats (CR). Norepinephrin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 2004-11, Vol.53 (11), p.1424-1432
Hauptverfasser: URANO, Yuriko, SAKURAI, Tomonobu, UEDA, Hiroshi, OGASAWARA, Junetsu, SAKURAI, Takuya, TAKEI, Megumi, IZAWA, Tetsuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1432
container_issue 11
container_start_page 1424
container_title Metabolism, clinical and experimental
container_volume 53
creator URANO, Yuriko
SAKURAI, Tomonobu
UEDA, Hiroshi
OGASAWARA, Junetsu
SAKURAI, Takuya
TAKEI, Megumi
IZAWA, Tetsuya
description The effect of exercise training (9 weeks of running) on norepinephrine-induced inhibition of insulin secretion was examined in rat islets. Insulin secretions from islets in the presence of glucose (> or =5.5 mmol/L) were significantly lower in trained (TR) than in control rats (CR). Norepinephrine inhibited 5.5 mmol/L glucose-stimulated insulin secretions and cyclic adenosine monophosphate (cAMP) contents in a dose-dependent manner in CR. Norepinephrine (10 micromol/L)-induced inhibition of insulin secretion was reversed by the blockade of the alpha(2)-adrenergic receptor in CR, but not in TR. Exercise training substantially shifted the dose-dependent curve for clonidine-induced inhibition of insulin secretions and that of cAMP contents to the right. Exercise training did not alter the density of the alpha(2)-adrenergic receptor either per islet or per protein of islet crude membrane. However, exercise training significantly reduced the protein expression of G alpha i-2 without change in G alpha i-2 mRNA. In CR but not in TR, norepinephrine significantly inhibited insulin secretions elicited by a combination of high glucose, a protein kinase C activator, and an adenylate cyclase activator under Ca(2+)-free conditions. Thus, exercise training appears to provoke a decreased expression of G alpha i-2 protein. This, at least in part, results in loss of the inhibitory effect of norepinephrine either on cAMP content or on insulin secretion at the post-calcium events in stimulus-secretion coupling, which, in turn, leads to the blunted inhibitory effects of norepinephrine on insulin secretion.
doi_str_mv 10.1016/j.metabol.2004.06.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67067896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67067896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-b94b11c6ba10e23a77f0705cb188ade16a96f0e498bba65966a8f9fef9ed401d3</originalsourceid><addsrcrecordid>eNpFkM1u1TAQRi0EopfCI4C8obuEcX6cZIkKpZUqsaFry3HGur5K7ODxlSgbXr0OjdSNR9ac77N8GPsooBQg5JdTuWDSY5jLCqApQZYA_St2EG1dFb0EeM0OAJUsoBnaC_aO6AQAXdfLt-xCtG0t20Ee2L9vSOjJJfdXJxc8D5anI3Lnj250KcRHjtaiSdvCh4ir87geYz55pp2n8-w8JzQR_-dtDAtftc_3XGi4oxkTbWn8g9E4wiJFneMTjzrRe_bG6pnwwz4v2cPN91_Xt8X9zx9311_vC9OASMU4NKMQRo5aAFa17joLHbRmFH2vJxRSD9ICNkM_jnr7mdS9HSzaAadcMNWX7Oq5d43h9xkpqcWRwXnWHsOZlOxAdv0gM9g-gyYGoohWrdEtOj4qAWozr05qN6828wqkyuZz7tP-wHlccHpJ7aoz8HkHNBk925gdOXrhZCXbqm7qJ7QTkpk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67067896</pqid></control><display><type>article</type><title>Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>URANO, Yuriko ; SAKURAI, Tomonobu ; UEDA, Hiroshi ; OGASAWARA, Junetsu ; SAKURAI, Takuya ; TAKEI, Megumi ; IZAWA, Tetsuya</creator><creatorcontrib>URANO, Yuriko ; SAKURAI, Tomonobu ; UEDA, Hiroshi ; OGASAWARA, Junetsu ; SAKURAI, Takuya ; TAKEI, Megumi ; IZAWA, Tetsuya</creatorcontrib><description>The effect of exercise training (9 weeks of running) on norepinephrine-induced inhibition of insulin secretion was examined in rat islets. Insulin secretions from islets in the presence of glucose (&gt; or =5.5 mmol/L) were significantly lower in trained (TR) than in control rats (CR). Norepinephrine inhibited 5.5 mmol/L glucose-stimulated insulin secretions and cyclic adenosine monophosphate (cAMP) contents in a dose-dependent manner in CR. Norepinephrine (10 micromol/L)-induced inhibition of insulin secretion was reversed by the blockade of the alpha(2)-adrenergic receptor in CR, but not in TR. Exercise training substantially shifted the dose-dependent curve for clonidine-induced inhibition of insulin secretions and that of cAMP contents to the right. Exercise training did not alter the density of the alpha(2)-adrenergic receptor either per islet or per protein of islet crude membrane. However, exercise training significantly reduced the protein expression of G alpha i-2 without change in G alpha i-2 mRNA. In CR but not in TR, norepinephrine significantly inhibited insulin secretions elicited by a combination of high glucose, a protein kinase C activator, and an adenylate cyclase activator under Ca(2+)-free conditions. Thus, exercise training appears to provoke a decreased expression of G alpha i-2 protein. This, at least in part, results in loss of the inhibitory effect of norepinephrine either on cAMP content or on insulin secretion at the post-calcium events in stimulus-secretion coupling, which, in turn, leads to the blunted inhibitory effects of norepinephrine on insulin secretion.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2004.06.008</identifier><identifier>PMID: 15536596</identifier><language>eng</language><publisher>New York, NY: Elsevier</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Adrenergic alpha-Antagonists - pharmacology ; Animals ; Biological and medical sciences ; Blood Glucose - metabolism ; Blotting, Western ; Clonidine - pharmacology ; Cyclic AMP - metabolism ; Dose-Response Relationship, Drug ; Down-Regulation ; Endocrine pancreas ; Fundamental and applied biological sciences. Psychology ; GTP-Binding Protein alpha Subunit, Gi2 ; GTP-Binding Protein alpha Subunits, Gi-Go - genetics ; GTP-Binding Protein alpha Subunits, Gi-Go - metabolism ; Hormones. Régulation ; In Vitro Techniques ; Insulin - metabolism ; Insulin Secretion ; Islets of Langerhans - metabolism ; Male ; Norepinephrine - pharmacology ; Norepinephrine - physiology ; Physical Conditioning, Animal ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Rats ; Rats, Wistar ; Receptors, Adrenergic, alpha-2 - drug effects ; Receptors, Adrenergic, alpha-2 - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA - analysis ; Vertebrates: endocrinology ; Yohimbine - pharmacology</subject><ispartof>Metabolism, clinical and experimental, 2004-11, Vol.53 (11), p.1424-1432</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-b94b11c6ba10e23a77f0705cb188ade16a96f0e498bba65966a8f9fef9ed401d3</citedby><cites>FETCH-LOGICAL-c401t-b94b11c6ba10e23a77f0705cb188ade16a96f0e498bba65966a8f9fef9ed401d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16265234$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15536596$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>URANO, Yuriko</creatorcontrib><creatorcontrib>SAKURAI, Tomonobu</creatorcontrib><creatorcontrib>UEDA, Hiroshi</creatorcontrib><creatorcontrib>OGASAWARA, Junetsu</creatorcontrib><creatorcontrib>SAKURAI, Takuya</creatorcontrib><creatorcontrib>TAKEI, Megumi</creatorcontrib><creatorcontrib>IZAWA, Tetsuya</creatorcontrib><title>Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>The effect of exercise training (9 weeks of running) on norepinephrine-induced inhibition of insulin secretion was examined in rat islets. Insulin secretions from islets in the presence of glucose (&gt; or =5.5 mmol/L) were significantly lower in trained (TR) than in control rats (CR). Norepinephrine inhibited 5.5 mmol/L glucose-stimulated insulin secretions and cyclic adenosine monophosphate (cAMP) contents in a dose-dependent manner in CR. Norepinephrine (10 micromol/L)-induced inhibition of insulin secretion was reversed by the blockade of the alpha(2)-adrenergic receptor in CR, but not in TR. Exercise training substantially shifted the dose-dependent curve for clonidine-induced inhibition of insulin secretions and that of cAMP contents to the right. Exercise training did not alter the density of the alpha(2)-adrenergic receptor either per islet or per protein of islet crude membrane. However, exercise training significantly reduced the protein expression of G alpha i-2 without change in G alpha i-2 mRNA. In CR but not in TR, norepinephrine significantly inhibited insulin secretions elicited by a combination of high glucose, a protein kinase C activator, and an adenylate cyclase activator under Ca(2+)-free conditions. Thus, exercise training appears to provoke a decreased expression of G alpha i-2 protein. This, at least in part, results in loss of the inhibitory effect of norepinephrine either on cAMP content or on insulin secretion at the post-calcium events in stimulus-secretion coupling, which, in turn, leads to the blunted inhibitory effects of norepinephrine on insulin secretion.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Blotting, Western</subject><subject>Clonidine - pharmacology</subject><subject>Cyclic AMP - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation</subject><subject>Endocrine pancreas</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GTP-Binding Protein alpha Subunit, Gi2</subject><subject>GTP-Binding Protein alpha Subunits, Gi-Go - genetics</subject><subject>GTP-Binding Protein alpha Subunits, Gi-Go - metabolism</subject><subject>Hormones. Régulation</subject><subject>In Vitro Techniques</subject><subject>Insulin - metabolism</subject><subject>Insulin Secretion</subject><subject>Islets of Langerhans - metabolism</subject><subject>Male</subject><subject>Norepinephrine - pharmacology</subject><subject>Norepinephrine - physiology</subject><subject>Physical Conditioning, Animal</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Adrenergic, alpha-2 - drug effects</subject><subject>Receptors, Adrenergic, alpha-2 - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA - analysis</subject><subject>Vertebrates: endocrinology</subject><subject>Yohimbine - pharmacology</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1u1TAQRi0EopfCI4C8obuEcX6cZIkKpZUqsaFry3HGur5K7ODxlSgbXr0OjdSNR9ac77N8GPsooBQg5JdTuWDSY5jLCqApQZYA_St2EG1dFb0EeM0OAJUsoBnaC_aO6AQAXdfLt-xCtG0t20Ee2L9vSOjJJfdXJxc8D5anI3Lnj250KcRHjtaiSdvCh4ir87geYz55pp2n8-w8JzQR_-dtDAtftc_3XGi4oxkTbWn8g9E4wiJFneMTjzrRe_bG6pnwwz4v2cPN91_Xt8X9zx9311_vC9OASMU4NKMQRo5aAFa17joLHbRmFH2vJxRSD9ICNkM_jnr7mdS9HSzaAadcMNWX7Oq5d43h9xkpqcWRwXnWHsOZlOxAdv0gM9g-gyYGoohWrdEtOj4qAWozr05qN6828wqkyuZz7tP-wHlccHpJ7aoz8HkHNBk925gdOXrhZCXbqm7qJ7QTkpk</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>URANO, Yuriko</creator><creator>SAKURAI, Tomonobu</creator><creator>UEDA, Hiroshi</creator><creator>OGASAWARA, Junetsu</creator><creator>SAKURAI, Takuya</creator><creator>TAKEI, Megumi</creator><creator>IZAWA, Tetsuya</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats</title><author>URANO, Yuriko ; SAKURAI, Tomonobu ; UEDA, Hiroshi ; OGASAWARA, Junetsu ; SAKURAI, Takuya ; TAKEI, Megumi ; IZAWA, Tetsuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-b94b11c6ba10e23a77f0705cb188ade16a96f0e498bba65966a8f9fef9ed401d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Blotting, Western</topic><topic>Clonidine - pharmacology</topic><topic>Cyclic AMP - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation</topic><topic>Endocrine pancreas</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GTP-Binding Protein alpha Subunit, Gi2</topic><topic>GTP-Binding Protein alpha Subunits, Gi-Go - genetics</topic><topic>GTP-Binding Protein alpha Subunits, Gi-Go - metabolism</topic><topic>Hormones. Régulation</topic><topic>In Vitro Techniques</topic><topic>Insulin - metabolism</topic><topic>Insulin Secretion</topic><topic>Islets of Langerhans - metabolism</topic><topic>Male</topic><topic>Norepinephrine - pharmacology</topic><topic>Norepinephrine - physiology</topic><topic>Physical Conditioning, Animal</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Adrenergic, alpha-2 - drug effects</topic><topic>Receptors, Adrenergic, alpha-2 - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA - analysis</topic><topic>Vertebrates: endocrinology</topic><topic>Yohimbine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>URANO, Yuriko</creatorcontrib><creatorcontrib>SAKURAI, Tomonobu</creatorcontrib><creatorcontrib>UEDA, Hiroshi</creatorcontrib><creatorcontrib>OGASAWARA, Junetsu</creatorcontrib><creatorcontrib>SAKURAI, Takuya</creatorcontrib><creatorcontrib>TAKEI, Megumi</creatorcontrib><creatorcontrib>IZAWA, Tetsuya</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>URANO, Yuriko</au><au>SAKURAI, Tomonobu</au><au>UEDA, Hiroshi</au><au>OGASAWARA, Junetsu</au><au>SAKURAI, Takuya</au><au>TAKEI, Megumi</au><au>IZAWA, Tetsuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>53</volume><issue>11</issue><spage>1424</spage><epage>1432</epage><pages>1424-1432</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>The effect of exercise training (9 weeks of running) on norepinephrine-induced inhibition of insulin secretion was examined in rat islets. Insulin secretions from islets in the presence of glucose (&gt; or =5.5 mmol/L) were significantly lower in trained (TR) than in control rats (CR). Norepinephrine inhibited 5.5 mmol/L glucose-stimulated insulin secretions and cyclic adenosine monophosphate (cAMP) contents in a dose-dependent manner in CR. Norepinephrine (10 micromol/L)-induced inhibition of insulin secretion was reversed by the blockade of the alpha(2)-adrenergic receptor in CR, but not in TR. Exercise training substantially shifted the dose-dependent curve for clonidine-induced inhibition of insulin secretions and that of cAMP contents to the right. Exercise training did not alter the density of the alpha(2)-adrenergic receptor either per islet or per protein of islet crude membrane. However, exercise training significantly reduced the protein expression of G alpha i-2 without change in G alpha i-2 mRNA. In CR but not in TR, norepinephrine significantly inhibited insulin secretions elicited by a combination of high glucose, a protein kinase C activator, and an adenylate cyclase activator under Ca(2+)-free conditions. Thus, exercise training appears to provoke a decreased expression of G alpha i-2 protein. This, at least in part, results in loss of the inhibitory effect of norepinephrine either on cAMP content or on insulin secretion at the post-calcium events in stimulus-secretion coupling, which, in turn, leads to the blunted inhibitory effects of norepinephrine on insulin secretion.</abstract><cop>New York, NY</cop><pub>Elsevier</pub><pmid>15536596</pmid><doi>10.1016/j.metabol.2004.06.008</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2004-11, Vol.53 (11), p.1424-1432
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_67067896
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic alpha-Agonists - pharmacology
Adrenergic alpha-Antagonists - pharmacology
Animals
Biological and medical sciences
Blood Glucose - metabolism
Blotting, Western
Clonidine - pharmacology
Cyclic AMP - metabolism
Dose-Response Relationship, Drug
Down-Regulation
Endocrine pancreas
Fundamental and applied biological sciences. Psychology
GTP-Binding Protein alpha Subunit, Gi2
GTP-Binding Protein alpha Subunits, Gi-Go - genetics
GTP-Binding Protein alpha Subunits, Gi-Go - metabolism
Hormones. Régulation
In Vitro Techniques
Insulin - metabolism
Insulin Secretion
Islets of Langerhans - metabolism
Male
Norepinephrine - pharmacology
Norepinephrine - physiology
Physical Conditioning, Animal
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Rats
Rats, Wistar
Receptors, Adrenergic, alpha-2 - drug effects
Receptors, Adrenergic, alpha-2 - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA - analysis
Vertebrates: endocrinology
Yohimbine - pharmacology
title Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Desensitization%20of%20the%20inhibitory%20effect%20of%20norepinephrine%20on%20insulin%20secretion%20from%20pancreatic%20islets%20of%20exercise-trained%20rats&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=URANO,%20Yuriko&rft.date=2004-11-01&rft.volume=53&rft.issue=11&rft.spage=1424&rft.epage=1432&rft.pages=1424-1432&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2004.06.008&rft_dat=%3Cproquest_cross%3E67067896%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67067896&rft_id=info:pmid/15536596&rfr_iscdi=true